HIV testing in the setting of inpatient acute substance abuse treatment.

HIV testing in the setting of inpatient acute substance abuse treatment.
复制标题

住院急性药物滥用治疗中的艾滋病毒检测。

DOI:
10.1081/ada-100104514
复制
发表时间:
2001
期刊:
The American journal of drug and alcohol abuse
影响因子:
--
通讯作者:
Lally,M
Lally,M
中科院分区:
--
文献类型:
--
作者:
Pugatch,D;Levesque,B;Greene,S;Strong,L;Flanigan,T;Lally,M

文献摘要

相似文献

我们调查了急性药物滥用治疗中患者对 HIV 检测的态度,并确定了新英格兰国家资助的住院戒毒中心提供人体免疫缺陷病毒 (HIV) 常规现场检测的普遍程度。对罗德岛州仅有的两个国家资助的住院戒毒治疗中心的患者(N = 66 名受访者)进行了自愿问卷调查,并对新英格兰地区所有国家资助的住院戒毒设施进行了电话调查。在新英格兰,所有国家资助的住院戒毒机构中有 17/38 (44.7%) 不定期向客户提供现场艾滋病毒检测。在参与者中,97% 的人对“您认为像这样的戒毒设施中的患者应该接受艾滋病毒检测吗?”这一问题做出了积极回应。 89% 的人表示,与其他地方相比,在戒毒治疗期间,他们能够“大致相同”或“更好”地应对艾滋病毒检测结果呈阳性的情况。大多数参与者将 Orasure® HIV 检测(一种 HIV-1 跨粘膜抗体检测)列为他们在药物治疗期间最喜欢的检测。然而,59% 的患者回应,所提供的测试类型不会对他们是否选择测试产生影响。大多数患者表示,在艾滋病毒感染诊断呈阳性后的几天内,他们希望去看医生。尽管围绕向住院急性药物滥用治疗患者提供艾滋病毒检测存在争议,但只要有现成的艾滋病毒临床护理,这些患者就需要进行艾滋病毒检测。
We examined patients' attitudes toward HIV testing in the setting of acute substance abuse treatment and determined the prevalence of offering routine on-site testing for human immunodeficiency virus (HIV) in inpatient state-funded detoxification centers in New England. Voluntary questionnaires were administered to patients (N= 66 respondents) at the only two state-funded inpatient drug detoxification treatment centers in Rhode Island, and a telephone survey of all state-funded inpatient detoxification facilities across the New England area was conducted. In New England, 17/38 (44.7%) of all state-funded inpatient detoxification facilities did not routinely offer on-site HIV testing to clients. Of participants, 97% responded positively to the question, “Do you think HIV testing should be available to patients in drug detoxification facilities such as this one?” There were 89% who reported that they would cope “about the same” or “better” with receiving a positive HIV test result while in detoxification treatment versus elsewhere. The greatest number of participants ranked the Orasure® HIV test, an assay for HIV-1 transmucosal antibody, as the test they would most prefer while in drug treatment. However, 59% of patients responded that the type of test offered would not make a difference in whether they chose testing. Most patients indicated that they would want to see a physician within a few days of a positive diagnosis of HIV infection. Despite the controversy surrounding the provision of HIV testing to patients in inpatient acute substance abuse treatment, HIV testing is desired among these patients provided that HIV clinical care is readily available.